Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

470 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma.
Bacharier LB, Guilbert TW, Zeiger RS, Strunk RC, Morgan WJ, Lemanske RF Jr, Moss M, Szefler SJ, Krawiec M, Boehmer S, Mauger D, Taussig LM, Martinez FD; Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute. Bacharier LB, et al. Among authors: szefler sj. J Allergy Clin Immunol. 2009 May;123(5):1077-82, 1082.e1-5. doi: 10.1016/j.jaci.2008.12.1120. Epub 2009 Feb 23. J Allergy Clin Immunol. 2009. PMID: 19230959 Free PMC article.
Factors to Consider in Prescribing Asthma Biologic Therapies to Children.
Anderson WC 3rd, Banzon TM, Chawes B, Papadopoulos NG, Phipatanakul W, Szefler SJ. Anderson WC 3rd, et al. Among authors: szefler sj. J Allergy Clin Immunol Pract. 2023 Mar;11(3):693-701. doi: 10.1016/j.jaip.2022.12.038. Epub 2023 Jan 13. J Allergy Clin Immunol Pract. 2023. PMID: 36646381
Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population.
Corren J, Szefler SJ, Sher E, Korenblat P, Soong W, Hanania NA, Berman G, Brusselle G, Zitnik R, Natalie CR, Sun L, Siu K, Wu WS, Lio P, Armstrong AW. Corren J, et al. Among authors: szefler sj. J Allergy Clin Immunol Pract. 2024 May;12(5):1215-1224.e3. doi: 10.1016/j.jaip.2024.02.007. Epub 2024 Feb 14. J Allergy Clin Immunol Pract. 2024. PMID: 38360213 Free article. Clinical Trial.
Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthma.
Papadopoulos NG, Szefler SJ, Bacharier LB, Maspero JF, Domingo C, Fiocchi A, Lee JK, Daizadeh N, Lederer DJ, Hardin M, Gall R, Djandji M, Siddiqui S, Jacob-Nara JA, Deniz Y, Rowe PJ. Papadopoulos NG, et al. Among authors: szefler sj. Allergy. 2023 Aug;78(8):2157-2167. doi: 10.1111/all.15743. Epub 2023 May 25. Allergy. 2023. PMID: 37059696
Digital health in difficult-to-treat severe asthma.
Busse WW, Szefler SJ. Busse WW, et al. Among authors: szefler sj. Lancet Respir Med. 2023 Jul;11(7):578-579. doi: 10.1016/S2213-2600(23)00012-7. Epub 2023 Mar 21. Lancet Respir Med. 2023. PMID: 36963416 No abstract available.
Treating asthma in the time of COVID.
Carr TF, Fajt ML, Kraft M, Phipatanakul W, Szefler SJ, Zeki AA, Peden DB, White SR; Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network Research Group. Carr TF, et al. Among authors: szefler sj. J Allergy Clin Immunol. 2023 Apr;151(4):809-817. doi: 10.1016/j.jaci.2022.12.800. Epub 2022 Dec 14. J Allergy Clin Immunol. 2023. PMID: 36528110 Free PMC article.
470 results